Literature DB >> 22416968

Lichen planus and lichenoid drug-induced eruption: a histological and immunohistochemical study.

Denise Lage1, Priscila Bianchini Juliano, Konradin Metze, Elemir Macedo de Souza, Maria Letícia Cintra.   

Abstract

INTRODUCTION: Lichenoid drug eruption (LDE) shares similar features with lichen planus (LP), that could reflect the same pathogenesis. In LP, an autoimmune attack is accepted and cytotoxic T-lymphocytes (CD8+) predominate, especially in late lesions. Apoptosis of keratinocytes may be mediated by CD8+ T and NK cells in two distinct ways: by the release of cytotoxic molecules such as perforin and granzyme B or by the Fas/FasL system. The immunological mechanisms involved in LDE are not yet fully established.
OBJECTIVES: Investigate immunohistological features in LP and LDE to add clues to better understand their pathogenesis.
MATERIAL AND METHODS: Twenty-two patients fulfilled all clinical, laboratory, histopathological, and follow-up features of lichen planus (n = 16) and lichenoid drug eruption (n = 6). Classic histological features favoring LP or LDE were evaluated by two observers. HAM56, MAC387, UCHL-1, OPD4, CD8, Granzyme B, Perforin, and ICAM-1 antibodies were used to decorate the immune infiltrate. Results were analyzed through Pearson correlation, Student's t-test, and linear discriminant analysis.
RESULTS: A higher number of necrotic keratinocytes as well as plasma cells and eosinophils within inflammatory cells were associated with LDE diagnosis. Only in LDE, a correlation was found between the number of T and CD8+ cells and between the number of granzyme B+ cells and apoptotic keratinocytes.
CONCLUSION: Our findings suggest a more important role of CD8+ granzyme B-containing cells in LDE group, being its synthesis associated with more intense apoptosis. So, LP and LDE may have a somewhat distinct pathogenesis.
© 2012 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22416968     DOI: 10.1111/j.1365-4632.2011.05113.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

1.  [Cutaneous drug reactions imitating dermatoses].

Authors:  N Magnolo; T Schwarz; S Ständer
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

Review 2.  Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis.

Authors:  Farzam Gorouhi; Parastoo Davari; Nasim Fazel
Journal:  ScientificWorldJournal       Date:  2014-01-30

3.  Fenofibrate-Induced Lichenoid Drug Eruption: A Rare Culprit.

Authors:  Fayeza Mohammed; Laura L Wally; Jeffrey E Karaban; Vijaya B Reddy; Yongsuk Lertratanakul
Journal:  Case Rep Dermatol       Date:  2017-11-14

Review 4.  Adverse Immunologically Mediated Oral Mucosal Reactions to Systemic Medication: Lichenoid Tissue Reaction/Interface Dermatitis-Stomatitis, Autoimmune Vesiculobullous Disease, and IgE-Dependent and Immune Complex Reactions.

Authors:  R A G Khammissa; R Chandran; A Masilana; J Lemmer; L Feller
Journal:  J Immunol Res       Date:  2018-06-10       Impact factor: 4.818

5.  Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction.

Authors:  Valerio Russo; Theo Klein; Darielle J Lim; Nestor Solis; Yoan Machado; Sho Hiroyasu; Layla Nabai; Yue Shen; Matthew R Zeglinski; Hongyan Zhao; Cameron P Oram; Peter A Lennox; Nancy Van Laeken; Nick J Carr; Richard I Crawford; Claus-Werner Franzke; Christopher M Overall; David J Granville
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

6.  Immune checkpoint inhibitor induced lichenoid reactions: A systematic review of characteristics and treatment outcomes.

Authors:  Abrahim Abduelmula; Ramsha Awan; Hammad Saif; Jessica Howard
Journal:  JAAD Int       Date:  2022-02-22

7.  A Case Report of Pirfenidone-Induced Lichenoid Drug Eruption in a Patient with Idiopathic Pulmonary Fibrosis.

Authors:  Seung Ah Yoo; Hyo Eun Park; Miri Kim; Hyun Jeong Park
Journal:  Ann Dermatol       Date:  2022-03-24       Impact factor: 1.444

8.  Lichen Planus Eruption Following Oxford-AstraZeneca COVID-19 Vaccine Administration: A Case Report and Review of Literature.

Authors:  Hamzeh M Alrawashdeh; Omar Al-Habahbeh; Abdallah Y Naser; Hashem Abu Serhan; Omar Hamdan; Kanar Sweiss; Yousef Aldalameh
Journal:  Cureus       Date:  2022-02-27

9.  VCAM1 and ICAM1 expression in oral lichen planus.

Authors:  Maryam Seyedmajidi; Shahryar Shafaee; Ali Bijani; Soodabeh Bagheri
Journal:  Int J Mol Cell Med       Date:  2013

10.  Clinical, Histopathological Characteristics and Immunohistochemical Findings in Lichen Planus Pigmentosus.

Authors:  Ramesh M Bhat; Teena Ramesh Mathanda; C S Jayaprakash; Sukumar Dandakeri
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.